Targeting the dynamic HSP90 complex in cancerJane B. Trepel, Len Neckers|Nature reviews. Cancer|2010Cited by 1.5k
Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutationsFatima Karzai, William L. Dahut, Kathleen Kelly et al.|Journal for ImmunoTherapy of Cancer|2018Cited by 312
Destabilization of Raf-1 by Geldanamycin Leads to Disruption of the Raf-1–MEK–Mitogen-Activated Protein Kinase Signalling PathwayTheodor W. Schulte, Leonard Μ. Neckers, Mikhail V. Blagosklonny et al.|Molecular and Cellular Biology|1996Cited by 275
Clinical Evaluation and Biomarker Profiling of Hsp90 InhibitorsAkira Yuno, Jane B. Trepel, Min-Jung Lee et al.|Methods in molecular biology|2017Cited by 122
Rebalancing Protein Homeostasis Enhances Tumor Antigen PresentationAlex M. Jaeger, Luke Whitesell, Lauren Stopfer et al.|Clinical Cancer Research|2019Cited by 61